- Double Mastectomy May Offer No Survival Benefit to Women With Breast Cancer
- Toxic Lead Found in Cinnamon Product, FDA Says
- Certain Abbott Blood Sugar Monitors May Give Incorrect Readings
- Athletes Can Expect High Ozone, Pollen Counts for Paris Olympics
- Fake Oxycontin Pills Widespread and Potentially Deadly: Report
- Shingles Vaccine Could Lower Dementia Risk
- Your Odds for Accidental Gun Death Rise Greatly in Certain States
- Kids From Poorer Families Less Likely to Survive Cancer
- Tough Workouts Won’t Trigger Cardiac Arrest in Folks With Long QT Syndrome
- At-Home Colon Cancer Test Can Save Lives
Hepatitis C Patients With HIV May Face Higher Risk of Liver Disease
Among people with hepatitis C, the risk of serious liver disease is much higher in those who also have HIV than in those without the AIDS-causing virus, a new study finds.
This is true even among patients with HIV who are otherwise benefiting from antiretroviral therapy to treat the virus, the University of Pennsylvania researchers said.
They analyzed data from more than 4,200 patients with both hepatitis C and HIV who were receiving antiretroviral therapy. In addition, they looked at data on more than 6,000 patients with hepatitis C only. The patients received care between 1997 and 2010.
The HIV/hepatitis C patients had an 80 percent higher rate of serious liver disease than those with hepatitis C only, according to the study, which was published in the March 18 issue of the journal Annals of Internal Medicine.
Even HIV/hepatitis C patients who had a good response to antiretroviral therapy for HIV still had a 60 percent higher rate of serious liver disease than those with hepatitis C alone.
Serious liver diseases were higher among HIV/hepatitis C patients with advanced liver fibrosis, diabetes and severe anemia, and among those who weren’t black, the study also found.
“Our results suggest that serious consideration should be given to initiating hepatitis C treatment in patients co-infected with HIV and hepatitis C — particularly among those with advanced liver fibrosis or cirrhosis — in order to try to reduce the risk of serious, potentially life-threatening liver complications,” study lead author Dr. Vincent Lo Re III, said in a university news release.
Lo Re is an assistant professor of medicine and epidemiology in the university’s division of infectious diseases and the department of biostatistics and epidemiology, as well as an investigator at the Penn Center for AIDS Research.
“By taking action sooner, we may be able to reduce the risk of advanced liver disease in co-infected patients,” Lo Re added.
About 20 percent to 30 percent of HIV patients also have hepatitis C, likely due to shared causes of infection.
More information
AIDS.gov has more about HIV and hepatitis.
Source: HealthDay
Copyright © 2024 HealthDay. All rights reserved.